Shanghai Pharmaceuticals Holdings Co., Ltd. financial statements, including revenue, expenses, profit, and loss

The total revenue of SHPMY for the last quarter is 9.73 B USD, and it's 12.37% higher compared to the previous quarter. The net income of Q1 24 is 214.56 M USD.